December 13, 2024 12:31 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda
Adar Poonawalla
Adar Poonawalla Twitter page

Production of Covishield is on schedule, remains unaffected by fire tragedy: Serum Institute CEO Adar Poonawalla

| @indiablooms | Jan 22, 2021, at 11:56 pm

Pune: A day after a massive fire hit vaccine-maker Serum Institute of India's Pune facility, company's CEO Adar Poonawalla on Friday assured the production of Covishield, the vaccine meant to fight against COVID-19, is on schedule and remains unaffected by the tragedy.

Maharashtra CM Uddhav Thackeray visited Serum Institute on Friday.

Speaking to reporters during a press conference with Uddhav Thackeray by his side, Poonawalla said: "This was a brand new facility."

 "No actual vaccine was actually being produced there, so there was no damage to any vaccine," he said.

He also tweeted: "Thank you Shri Uddhav Ji @CMOMaharashtra and @AUThackeray for visiting @SerumInstIndia and extending your help and support during this terrible crisis. As you have seen, the production of #COVISHIELD is on schedule and remains unaffected by this tragedy."

At least five people have been killed in the fire which broke out at an under-construction facility of India's biotechnology and pharmaceuticals company Serum Institute of India (SII) here on Thursday.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.